E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/1/2005 in the Prospect News Convertibles Daily.

New Issue: Morgan Stanley prices $24 million 7% Sparqs exchangeable for Forest Laboratories

New York, June 1 - Morgan Stanley priced $24 million of one-year 7% Sparqs (Stock Participation Accreting Redemption Quarterly-pay Securities) that are mandatorily exchangeable for the common stock of Forest Laboratories, Inc., according to a 424B3 filing with the Securities and Exchange Commission.

New York-based Forest Laboratories develops, manufactures and sells prescription and non-prescription pharmaceutical products.

Issuer:Morgan Stanley
Issue:Sparqs (Stock Participation Accreting Redemption Quarterly-pay Securities) senior medium-term notes, series F
Underlying stock:Forest Laboratories, Inc.
Amount:$23.9816 million
Maturity:June 1, 2006
Coupon:7%, payable quarterly
Price:Par of $19.34 (equal to one-half of the closing price of Forest Laboratories stock on the pricing date)
Exchange ratio:0.5 (mandatory, at maturity)
Call:Nov. 30, 2005 onwards at price to give yield to call of 16%
Pricing date:May 23
Settlement date:May 31
Underwriter:Morgan Stanley
Listing:"FOL" on American Stock Exchange

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.